Case Study

Thermidas

INITIAL SITUATION


The finnish health technology company Thermidas sought to evaluate the potential of entering the German healthcare market with its innovative infrared (IR) thermal imaging solution for medical diagnostics.

Thermidas’ CE-certified system enables clinicians and care professionals to detect and monitor conditions such as diabetic foot ulcers, inflammatory disorders, vascular conditions and pressure injuries through non-invasive temperature analysis.

Thermidas required a German-based partner capable of managing all operational aspects of market entry – from competitive landscape analysis and marketing to active lead generation and direct sales outreach. Costs and resource commitments were to be kept efficient. Above all, Thermidas needed a partner with deep expertise in the German digital health and MedTech sector.

The primary goal was to obtain a data-driven assessment of whether and to what extent a structured market entry and further investment in Germany would represent a viable strategic step for Thermidas.

THE BACKGROUND

What is Thermidas? 

Thermidas is a finnish health technology company headquartered in Tampere, Finland. The company specialises in infrared (IR) thermal imaging solutions for clinical and care settings. Its certified thermal imaging hardware, paired with proprietary software, allows healthcare professionals to analyse temperature anomalies on the body surface – supporting early diagnosis and treatment monitoring for a wide range of conditions including diabetic foot complications, arthritis, skin conditions and autonomic dysfunction.
Thermidas holds the world’s first Class IIa Medical Device CE certification for an IR thermal imaging system and is also FDA cleared. The solution is already in active clinical use across university hospitals and private clinics in Finland, and the company has begun expanding internationally.

Why DHP?

DHP positions itself as a full-service partner for digital health and MedTech companies seeking to enter the German market. With an interdisciplinary team spanning marketing, sales, regulatory affairs and IT, as well as an established network of healthcare and care sector stakeholders, DHP supports international companies in building a foundation for sustainable growth in Germany – efficiently and with measurable outcomes.

CONCLUSION

Jouni Kyllönen – CEO, Thermidas Oy

“Working with DHP continues to provide us with the clarity and local expertise we need to navigate the German healthcare market. Their structured approach and deep understanding of the MedTech sector have enabled us to make meaningful progress with confidence. Together, we have established valuable relationships, gained important market insights, and successfully initiated a clinical study in collaboration with Helios Hospital Wuppertal. The partnership has exceeded our expectations so far, and the DHP team has consistently been professional, responsive, and always committed to achieving results. We look very  much forward to continuing our collaboration as we further expand our presence in Germany.”

PROCEDURE AND SOLUTION

Digital Health Port partnered with Thermidas to support its market entry activities in Germany by providing strategic consulting, market development, and Sales Operations services.

Our collaboration combines market strategy, operational execution, targeted lead generation, and direct outreach to key decision-makers across the German healthcare sector, including hospitals as well as long-term care and nursing home providers. Throughout the project, Digital Health Port acts as Thermidas’ local partner, helping to identify market opportunities, establish valuable relationships, and drive commercial activities while providing ongoing strategic guidance tailored to the German healthcare market.

A key milestone of the still ongoing collaboration was the successful initiation of a clinical study with Helios Hospital Wuppertal. Digital Health Port facilitates the engagement with the clinical stakeholders, coordinates the collaboration process, and supports the operational implementation of the project. As part of the study, 3 Thermidas devices were deployed across multiple clinical departments, where they are currently being evaluated in routine clinical practice. The study provides Thermidas with valuable real-world experience while supporting the company’s long-term clinical validation and commercialization efforts in the German healthcare market. 

Scroll to Top